MOSAIC ONCOLOGY AS
Operating
Å drive med utvikling, lisensiering og salg av medisinsk diagnostiske
tester.
Selge medisinske tester av kreftsvulster for å hjelpe å raskere finne
rett type kreftbehandling.
Organization
- Chairman of the board
- DS
- Years since formation
- 10 years
- since Apr 15, 2016
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 90,000
- 1 share class
- Total number of shareholders
- 3
- 2 companies, 1 person
Financials
- Total operating income 2025
- 123,966
- NOK
- Annual total result 2025
- 8,453
- NOK
- Total equity 2025
- 3,477
- NOK
Last update: Jun 30, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
DS | Chairman | 33.33 % indirectly |
| Board Member | 33.33 % indirectly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
DS | Chairman | 33.33 % indirectly |
| Board Member | 33.33 % indirectly | |
SS | - | 33.33 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 33.33 % | |
| Ordinary shares | 30,000 | 33.33 % | |
SS | Ordinary shares | 30,000 | 33.33 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 123,966 | 30,840 | 1,668,562 | 1,865,762 | 2,582,255 |
Annual Total Result | 8,453 | -43,681 | -19,736 | -113,978 | -613,094 |
Total assets | 5,465 | 5,293 | 48,662 | 284,177 | 542,787 |
Total liabilities | 1,988 | 10,269 | 9,955 | 225,735 | 370,366 |
Total equity | 3,477 | -4,976 | 38,706 | 58,442 | 172,421 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 123,966 | 30,840 | 1,668,562 | 1,865,762 | 2,582,255 |
Total operating costs | 101,723 | 74,612 | 1,685,961 | 1,977,857 | 3,294,813 |
Operating result | 22,243 | -43,772 | -17,399 | -112,095 | -712,558 |
Financial income/costs | -13,790 | 91 | -2,337 | -1,883 | -24 |
Profit before tax | 8,453 | -43,681 | -19,736 | -113,978 | -712,582 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | -99,488 |
Annual Total Result | 8,453 | -43,681 | -19,736 | -113,978 | -613,094 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 911 | 911 | 14,684 | 31,135 | 46,677 |
Total current assets | 4,554 | 4,382 | 33,978 | 253,042 | 496,110 |
Total assets | 5,465 | 5,293 | 48,662 | 284,177 | 542,787 |
Short term debt | 1,988 | 10,269 | 9,955 | 225,735 | 370,366 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 1,988 | 10,269 | 9,955 | 225,735 | 370,366 |
Contributed capital | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 |
Retained earnings | -86,523 | -94,976 | -51,294 | -31,558 | 82,421 |
Total equity | 3,477 | -4,976 | 38,706 | 58,442 | 172,421 |
Total equity and liabilities | 5,465 | 5,293 | 48,661 | 284,177 | 542,787 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises